相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity
Mika Kato Kaneko et al.
CANCER SCIENCE (2012)
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis
Naoya Fujita et al.
JOURNAL OF BIOCHEMISTRY (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Podoplanin: emerging functions in development the immune system and cancer
Jillian L. Astarita et al.
FRONTIERS IN IMMUNOLOGY (2012)
Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies
Youya Nakazawa et al.
CANCER SCIENCE (2011)
Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation
Katsue Suzuki-Inoue
JOURNAL OF BIOCHEMISTRY (2011)
Contribution of platelets to tumour metastasis
Laurie J. Gay et al.
NATURE REVIEWS CANCER (2011)
Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin
Leah N. Cueni et al.
BLOOD (2010)
Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2 EMBRYONIC/NEONATAL LETHALITY OF CLEC-2-DEFICIENT MICE BY BLOOD/LYMPHATIC MISCONNECTIONS AND IMPAIRED THROMBUS FORMATION OF CLEC-2-DEFICIENT PLATELETS
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Amplification of chromosomal segment 4q12 in non-small cell lung cancer
Alex H. Ramos et al.
CANCER BIOLOGY & THERAPY (2009)
Platelets: Guardians of Tumor Vasculature
Benoit Ho-Tin-Noe et al.
CANCER RESEARCH (2009)
Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung
Yoshihisa Shimada et al.
CANCER SCIENCE (2009)
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass et al.
NATURE GENETICS (2009)
Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431
Naho Atsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Renal cells activate the platelet receptor CLEC-2 through podoplanin
Charita M. Christou et al.
BIOCHEMICAL JOURNAL (2008)
Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis
Youya Nakazawa et al.
BLOOD (2008)
Platelet granule secretion continuously prevents intratumor hemorrhage
Benoit Ho-Tin-Noe et al.
CANCER RESEARCH (2008)
Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma
Akikazu Kawase et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Angiogenesis is regulated by a novel mechanism:: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Joseph E. Italiano et al.
BLOOD (2008)
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis
Akiko Kunita et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
A. Lazo-Langner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor
Mika Kato Kaneko et al.
GENE (2006)
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
K Suzuki-Inoue et al.
BLOOD (2006)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma
Y Kato et al.
TUMOR BIOLOGY (2005)
Antitumor and antimetastatic effect of warfarin and heparins
V Bobek et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors
Y Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)